Insulin resistance does not have one universal cause. It usually results from interactions among genetic susceptibility, excess or dysfunctional adipose tissue, physical inactivity, dietary and energy-balance factors, ageing, hormonal influences, sleep and other medical conditions. The exact biological contribution of each factor varies between individuals. The strongest established clinical association is with excess body fat, particularly when adipose tissue accumulates in metabolically active locations such as the abdominal cavity and around internal organs. However, insulin resistance can occur in people who are not overweight, so it should not be defined simply as a consequence of body size. The NHS and NIDDK identify factors including excess weight, age and family history among contributors to type 2 diabetes risk.
Adipose tissue is an active endocrine organ rather than merely a passive storage depot. When adipose tissue expands excessively, particularly visceral adipose tissue, its metabolic behaviour can change. Enlarged adipocytes can release greater quantities of free fatty acids and alter the production of signalling molecules known as adipokines. Changes in adipokines and inflammatory mediators can affect insulin signalling in muscle and liver.
Visceral fat also has a direct connection to the portal circulation, which carries blood to the liver, making excess fatty-acid delivery particularly relevant to hepatic metabolism. These processes can contribute to hepatic insulin resistance and abnormal lipid metabolism. The relationship is therefore biological and metabolic rather than simply mechanical.
Physical inactivity can contribute to insulin resistance because skeletal muscle is a major site of glucose disposal. Muscle contraction stimulates glucose uptake through pathways that do not depend entirely on insulin. Regular physical activity also promotes adaptations in mitochondrial function, muscle glucose transport and metabolic flexibility. Conversely, prolonged inactivity reduces these beneficial adaptations and can worsen insulin sensitivity. This is one reason regular physical activity is recommended as part of prevention and management of type 2 diabetes. Exercise can improve glucose handling even without dramatic weight loss, demonstrating that the relationship between activity and insulin sensitivity is not mediated solely by changes in body weight.
Diet and energy balance can influence insulin resistance through several mechanisms, although no single food can be identified as the universal cause. Persistent energy excess can promote accumulation of adipose tissue and ectopic fat in organs such as the liver and skeletal muscle. Dietary patterns associated with excess calories, low nutritional quality and high consumption of energy-dense foods can contribute indirectly through weight gain and metabolic dysfunction. In contrast, dietary patterns rich in minimally processed foods, fibre and nutrient-dense ingredients can support weight management and metabolic health. The relationship should not be reduced to one nutrient or food because total energy intake, dietary composition, physical activity and individual metabolic characteristics interact.
Genetics and family history also influence susceptibility. Some people develop type 2 diabetes or insulin resistance at relatively modest levels of excess weight, whereas others remain metabolically healthy despite having substantial adiposity. Genetic differences can affect beta-cell function, fat distribution, insulin signalling and other metabolic pathways. Age is another risk factor, partly because body composition, physical activity, muscle mass and beta-cell function can change with age. Certain populations have higher observed risks of type 2 diabetes, reflecting complex interactions among genetics, environment, socioeconomic factors, diet, activity and other determinants rather than a simple biological explanation based on ancestry alone.
Medical and hormonal conditions can also produce or aggravate insulin resistance. Polycystic ovary syndrome is associated with insulin resistance in many affected people. Pregnancy normally produces physiological insulin resistance, which can become more pronounced and contribute to gestational diabetes when pancreatic insulin secretion cannot compensate adequately. Certain endocrine disorders and medications can also alter glucose metabolism and insulin sensitivity. Corticosteroids, for example, can raise blood glucose and promote insulin resistance.
Sleep disruption and conditions such as obstructive sleep apnoea have also been associated with metabolic dysfunction. Because multiple mechanisms can coexist, identifying the contributors in an individual may require consideration of medication, endocrine health, sleep, body composition, activity and family history rather than focusing on diet alone.
Chronic inflammation and ectopic lipid accumulation are important mechanistic concepts in modern understanding of insulin resistance. When excess fatty acids and lipid intermediates accumulate in liver and muscle cells, they can interfere with insulin signalling pathways. Adipose-tissue inflammation can increase cytokine signalling and alter normal metabolic communication. Mitochondrial dysfunction, oxidative stress and altered cellular signalling have also been investigated. These mechanisms do not mean that insulin resistance is simply an inflammatory disease; rather, inflammation, lipid metabolism and insulin signalling interact in a complex network. Research continues to determine which mechanisms are primary causes and which arise as consequences of metabolic dysfunction.
Insulin resistance can therefore be caused or promoted by multiple overlapping factors rather than a single behaviour or personal failing. Some causes are modifiable, such as physical inactivity and excess energy intake, while others, including genetics, age and some medical conditions, cannot simply be removed. Risk reduction focuses on factors that can be changed, including regular physical activity, appropriate nutrition, weight management where relevant, adequate sleep and management of associated medical conditions.
The purpose is not to imply that an individual caused their own insulin resistance, but to recognise that metabolic risk can sometimes be altered even when underlying susceptibility remains. The NHS and CDC both emphasise lifestyle measures such as healthy eating, regular physical activity and weight management as important ways to reduce type 2 diabetes risk.
